Latest immune responses News | Page 7

National study suggests new vaccine is needed to prevent childhood pneumonia
Lifetime investigating malaria leads to drugs that push back on resistance… And CSL Florey Medal
Australian venture capital fund joins partners in backing new immunotherapy
Ludwig Cancer Research study finds common, targetable mechanism tumors use to suppress immune responses
Gut parasites may increase onward transmission of respiratory bugs in rabbits
Burnet welcomes grant for mRNA vaccine development
TAG-VE statement on Omicron sublineages BQ.1 and XBB
Ludwig Chicago nanotechnology indicues therapeutic immune responses against multiple types of tumors
Alligators Exposed to PFAS Show Autoimmune Effects
Dr Michelle Boyle named 2023 CSL Centenary Fellow
UQ vaccine research targets lumpy skin disease
Going with your gut
Pollen does more than make you sneeze
Children and high-risk populations immune responses to vaccinations and Covid going under microscope
Ludwig Lausanne study identifies potential combination therapy for testing in deadly brain cancer
Monkeypox vaccine trial recruiting volunteers
Mucosal antibodies in airways protect against omicron infection
Research Team Creates More Effective Cancer Therapy
Vaccine Expected to Induce Strong Immune Responses Against 2022 Monkeypox Virus, Research Shows
Cells help immune system tolerate friendly gut bacteria
New research identifies bacterial ‘Jekyll and Hyde’ molecule involved in immune responses
Prestigious grant to profile responses to Covid vaccines in vulnerable people
MRFF grants to support Monash research into Covid
New insights into RTS,S efficacy and immune response in children
New Players in Immune Response
Risk of long COVID builds each time you get infected
Victoria’s first mRNA innovation hub backed by state government
Kids’ noses can better fight Covid
COVID vaccine patch fights variants better than needles
Maternal antibodies may protect babies from cytomegalovirus
Study reveals new mode of triggering immune responses
Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants
Elucidation of antiviral/innate immune response activation mechanism of hepatokine LECT2
Ludwig Oxford Member Yang Shi elected Member of European Molecular Biology Organization
Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN Phase III trial
COPD patients respond equally well to Covid vaccine
Attention Queenslanders – Your help needed for landmark Covid study
Interim statement on composition of current Covid vaccines
Interim statement on decision-making considerations for use of variant updated Covid vaccines
Australian drug trial aims to reduce hospital visits for kids with asthma
T cell behavior determines immunotherapy success
CSIRO’s future science to tackle energy storage, carbon locking, immune resilience and bioeconomy
Key protein facilitates regeneration of liver blood vessels
Participants sought for state-wide Covid vaccine study
Two distinct tuberculosis subtypes IDed – implications for personalized therapy
Expert commentary: fourth Covid vaccine dose for at-risk Australians
Study reveals structure of anti-tumor therapy’s target
Four Ludwig Cancer Research scientists named Fellows of American Association for Cancer Research